$112.28
2.60% (Daily)
Market Cap
$9.34B
Revenue
$1.24B
Rank by MCap
#633
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Headquarters
San Diego, CA
Employees
350
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
Loading chart…